Randomization & Trial Supply Management (RTSM)
Empowering Clinical Trials: Streamlining Randomization and Supply Management with RTSM Solutions
What is RTSM?
RTSM (Randomization and Trial Supply Management) systems enable study teams to manage patient randomization and supply investigational drugs, placebos, and/or medical devices to sites throughout the study lifecycle. RTSM systems are alternatively called Interactive Response Technology (IRT), which encompasses IWRS, IVRS, and IxRS (Interactive Web, Voice, and Voice/Web Response Systems).
These technologies supported site staff in obtaining study kit information, especially when computers were not widely available in surgical rooms. Today, web access is more prevalent in hospital settings, so staff may leverage centralized RTSM systems to manage patients dosages. IxRS is still commonly used throughout the world.


Patients must be assigned into different treatment arms via randomization to balance known and unknown subject attributes and demonstrate validity of statistical comparisons. This process is complicated due to Sponsor/CRO requirements such as double blindness (neither patient nor study team knowing which treatment was obtained), complex stratifications, and ability to recruit patients globally while maintaining oversight from a centralized location. With high volumes of subjects, it’s easy to incorrectly assign a randomization number or dispense the wrong treatment kit.
Unlike other clinical systems, such as CTMS and eTMF, that may be managed fully in-house, Sponsors typically rely on IRT vendors to set up studies and provide professional/validation services due to the build complexity.
Key Benefits of RTSM/IRT Systems
Efficient Randomization and Blind Protection
RTSM automates patient enrollment and randomization, reducing human error and bias. It ensures allocation concealment and maintains study blinding. RTSM...
Read MoreEfficient Randomization and Blind Protection
RTSM automates patient enrollment and randomization, reducing human error and bias. It ensures allocation concealment and maintains study blinding. RTSM systems have security settings that ensure only a restricted set of users may unblind the patient in case of emergency.
Read LessReduce Trial Delays
Advancements in IRT facilitate adaptive trial design, study start-up, and protocol amendment more quickly than ever. By leveraging pre-built libraries, Sponsors/CROs may shift...
Read MoreReduce Trial Delays
Advancements in IRT facilitate adaptive trial design, study start-up, and protocol amendment more quickly than ever. By leveraging pre-built libraries, Sponsors/CROs may shift away from study-by-study deployment to support mid-study changes. Automation supports cohort management, patient enrollment, drug dispensation, inventory management, and screen failures. With audit trails and user-based access, regulatory compliance is enforced throughout all these processes.
Read LessOptimize Trial Supply Management
Late or damaged shipments can result in patients receiving an unusable product or being disqualified for missing a dose. RTSM technology can not only track unused or...
Read MoreOptimize Trial Supply Management
Late or damaged shipments can result in patients receiving an unusable product or being disqualified for missing a dose. RTSM technology can not only track unused or returned drugs during the trial, but it can also be configured to support multiple direct-to-patient shipping scenarios. Resupply can be set predictively or automatically based on actual site enrollment numbers to ensure sites are adequately stocked. Furthermore, you can set system alerts for low depot supply, delayed shipments, and upcoming expiry dates.
Read LessImportant Considerations for RTSM Implementation
Implementation and vendor selection comprise an arduous process, and Sponsors are often unsure what to ask. As novel trial and master protocol designs evolve, the complexity of these decisions will likely grow. For a successful RTSM implementation, consider the following:
- Study Build Timelines: Sometimes, the core RTSM application will not meet every need of your trial design. Allocate time for the vendor to develop custom programming to incorporate your requirements into the system.
- Vendor Expertise: Choose an experienced vendor who acts as a partner, understands your study’s unique requirements, and provides expert advice. ProPharma specializes in vendor assessment, guiding your organization through RFX and system demos to select a fit-for-purpose system.
- Functionality and Flexibility: At a minimum, ensure that the system can accommodate complex protocols, adaptive studies, multiple-subject cohorts, and advanced randomization methods as needed for your drug/therapeutic area.
- Interoperability: Many clinical trial processes are housed in disparate systems; for example, Sponsors may wish to have the randomization form in EDC and site activation conducted in CTMS. RTSM systems should offer published APIs to integrate with EDC and CTMS.


Popular Vendors in the RTSM/IRT Space
- EndPoint PULSE: with pre-validated, configurable study components, PULSE streamlines system modifications and simplifies site, user, and supply management.
- Medidata RTSM: fully pre-validated solution that enables mid-study changes and integrates seamlessly with Rave EDC.
- Suvoda IRT: offers rich functionality in cohort/stage/phase management, adaptive replacement and randomization, and drug accountability and reconciliation.
- Veeva RTSM (previously Veracity Logic): modular, quick to configure, and offers features like screening, rescreening, adaptive randomizations, and cohort management.
- YPrime IRT: provides flexible supply management, Sponsor-controlled cohort management, and easy adjustment of dispensing levels.
ProPharma's RTSM Services & Approach
ProPharma’s R&D Technology team understands the criticality of selecting the right RTSM and excels in aligning your company’s needs with regulations and GxP system best practices. Our comprehensive approach and expert knowledge ensure that your organization is set up for long-term success.
Service Category |
How We Can Help |
Strategy & Business Process Optimization |
|
Clinical Research Solutions |
|
Implementation Support |
|
Validation |
|
Managed Services |
|
RTSM Consulting Expertise
If you want to implement or optimize your RTSM, ProPharma's R&D Technology team comprises experienced consultants who can advise your digital transformation. Contact us to speak with one of our RTSM / IRT experts today.
News & Insights

August 7, 2025
Orchestrating Excellence: How ProPharma Bridges Vendors to Deliver Unified, High...
Discover how ProPharma enhances collaboration and quality in drug development by expertly coordinating and communicating with multiple vendors for unified, high-quality outcomes.

August 4, 2025
European Marketing Authorization Success: The Critical Role of Quality and Compl...
Achieve European market success with robust quality and compliance solutions, ensuring seamless market entry and long-term growth through expert QP support

July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
.png?width=320&height=185&name=Global%20MLR%20Review%20(RS).png)
August 4, 2025
Simplifying Global MLR Review: Local Expertise at a Global Scale
Struggling to streamline MLR review across international markets? Discover how our team helped a leading pharmaceutical company reduce review timelines, ensure regulatory compliance, and eliminate...

July 29, 2025
Successfully Executing a Tech Transfer in a Week
Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

July 29, 2025
Avoiding Common Pitfalls During FDA Inspections
Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...
.png?width=320&height=185&name=labeling-webinar-thumbnail%20(1).png)
July 22, 2025
Inside FDA Review: Crafting a Quality ANDA Labeling Submission
Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...
News & Insights